Literature DB >> 26534761

Possible role of increased oxidative stress in pulmonary hypertension in experimental diaphragmatic hernia.

R Aras-López1, J A Tovar2,3, L Martínez2,3.   

Abstract

PURPOSE: Congenital diaphragmatic hernia (CDH) is one of the causes of respiratory failure in newborns due to lung hypoplasia and pulmonary abnormalities leading to pulmonary hypertension (PH). NAD(P)H oxidase (Nox) is a family of isoenzymes that generate reactive oxygen species (ROS) which can contribute to PH-induced vascular dysfunction. On the other hand, superoxide dismutase (SOD) 1-2 and catalase are the antioxidant enzymes that eliminate the excess of ROS in pulmonary vascular cells. Our aim is to examine whether PH-associated with CDH is due to a dysregulation of ROS production in lungs from CDH fetuses.
METHODS: Pregnant rats received either 100 mg nitrofen or vehicle on E9.5. Fetuses were recovered on E21. (1) Nox activity, (2) H2O2 production and (3) mRNA levels of Nox1, Nox2, Nox4, SOD1, SOD2 and catalase were analyzed in fetal lungs.
RESULTS: Nox activity and Nox1 and Nox2 mRNA levels were increased in the lungs of fetuses with CDH. However, there were no changes in H2O2 production and Nox4 mRNA levels. SOD1, SOD2 and catalase were decreased.
CONCLUSIONS: The raised oxidative stress due to increase in ROS generation by Nox isoenzymes and dysfunction of antioxidant enzymes seems to be a potential mechanism responsible on PH-associated with CDH.

Entities:  

Keywords:  Catalase; Congenial diaphragmatic hernia; Nitrofen; Nox; Pulmonary hypertension; ROS; SOD

Mesh:

Substances:

Year:  2015        PMID: 26534761     DOI: 10.1007/s00383-015-3826-5

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  30 in total

1.  Abnormal platelet-derived growth factor signaling accounting for lung hypoplasia in experimental congenital diaphragmatic hernia.

Authors:  Jens Dingemann; Takashi Doi; Elke Ruttenstock; Prem Puri
Journal:  J Pediatr Surg       Date:  2010-10       Impact factor: 2.545

2.  Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.

Authors:  Zachary Van Rheen; Cheryl Fattman; Shannon Domarski; Susan Majka; Dwight Klemm; Kurt R Stenmark; Eva Nozik-Grayck
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-10       Impact factor: 6.914

Review 3.  Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.

Authors:  Ulrich Förstermann
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-05-06

Review 4.  Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2012-03-23       Impact factor: 5.223

Review 5.  Pulmonary vascular development goes awry in congenital lung abnormalities.

Authors:  Heleen Kool; Daphne Mous; Dick Tibboel; Annelies de Klein; Robbert J Rottier
Journal:  Birth Defects Res C Embryo Today       Date:  2014-11-26

Review 6.  Reactive oxygen species, inflammation, and lung diseases.

Authors:  Di Paola Rosanna; Cuzzocrea Salvatore
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Effects of antioxidant vitamins on molecular regulators involved in lung hypoplasia induced by nitrofen.

Authors:  Salome Gonzalez-Reyes; Leopoldo Martinez; Wenceslao Martinez-Calonge; Virginia Fernandez-Dumont; Juan A Tovar
Journal:  J Pediatr Surg       Date:  2006-08       Impact factor: 2.545

8.  Oxidation-reduction (redox) controls fetal hypoplastic lung growth.

Authors:  Jason C Fisher; David E Kling; T Bernard Kinane; Jay J Schnitzer
Journal:  J Surg Res       Date:  2002-08       Impact factor: 2.192

9.  Effects of nitrofen and vitamins A, C and E on maturation of cultured human H441 pneumocytes.

Authors:  Salome Gonzalez-Reyes; Leopoldo Martinez; Wenceslao Martinez-Calonge; Virginia Fernandez-Dumont; Juan A Tovar
Journal:  Biol Neonate       Date:  2006-02-20

10.  Nitrofen-induced diaphragmatic hernias in rats: pulmonary antioxidant enzyme activities.

Authors:  W Sluiter; A P Bos; F Silveri; R Tenbrinck; R Kraakslee; D Tibboel; J F Koster; J C Molenaar
Journal:  Pediatr Res       Date:  1992-10       Impact factor: 3.756

View more
  4 in total

1.  Anti-oxidants correct disturbance of redox enzymes in the hearts of rat fetuses with congenital diaphragmatic hernia.

Authors:  Rosa Aras-López; L Almeida; V Andreu-Fernández; J Tovar; L Martínez
Journal:  Pediatr Surg Int       Date:  2017-10-27       Impact factor: 1.827

2.  Role of catalytic iron and oxidative stress in nitrofen-induced congenital diaphragmatic hernia and its amelioration by Saireito (TJ-114).

Authors:  Shima Hirako; Hiroyuki Tsuda; Fumiya Ito; Yasumasa Okazaki; Tasuku Hirayama; Hideko Nagasawa; Tomoko Nakano; Kenji Imai; Tomomi Kotani; Fumitaka Kikkawa; Shinya Toyokuni
Journal:  J Clin Biochem Nutr       Date:  2017-09-05       Impact factor: 3.114

Review 3.  The Role of Oxidative Stress in the Pathomechanism of Congenital Malformations.

Authors:  Nicola Laforgia; Antonio Di Mauro; Giovanna Favia Guarnieri; Dora Varvara; Lucrezia De Cosmo; Raffaella Panza; Manuela Capozza; Maria Elisabetta Baldassarre; Nicoletta Resta
Journal:  Oxid Med Cell Longev       Date:  2018-12-30       Impact factor: 6.543

4.  Lung Metabolomics Profiling of Congenital Diaphragmatic Hernia in Fetal Rats.

Authors:  Maria Del Mar Romero-Lopez; Marc Oria; Miki Watanabe-Chailland; Maria Florencia Varela; Lindsey Romick-Rosendale; Jose L Peiro
Journal:  Metabolites       Date:  2021-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.